ALPS Medical Breakthroughs ETF (SBIO) — ETF Analysis on Winston

Key Facts

• Issuer: ALPS Funds
• Asset Class: Stock
• Price: $65.15
• Expense Ratio: 50.00%
• Assets Under Management: $213M
• Number of Holdings: 103
• Inception Date: 2014-12-30
• Currency: USD

Winston Score

ALPS Medical Breakthroughs ETF has a Winston Score of 66 out of 100.

Performance

• 1-Year Return: 88.27%
• 3-Year Return: 84.88%
• 5-Year Return: 8.00%

Top Holdings

Crinetics Pharmaceuticals Inc. (N/A%), Apogee Therapeutics Inc. (N/A%), Xenon Pharmaceuticals Inc. (N/A%), CG oncology Inc. (N/A%), Dianthus Therapeutics Inc. (N/A%)

Sector Breakdown

Healthcare (N/A%)